SeroRepair
SeroRepair is a privately-held veterinary biotechnology company that develops SeroLube, a frozen donor-derived bovine plasma eye serum sold through veterinary distributors to clinics for treating animal ocular surface conditions.
- Company typePrivate
- Founded-
- HeadquartersKaysville, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What SeroRepair does
SeroRepair is a privately-held veterinary biotechnology company headquartered in Kaysville, Utah (590 N. Kays Drive, Unit 110), that develops biologic products aimed at simplifying ocular care for veterinary clinics, patients, and pet owners. The company's sole commercial product, SeroLube, is a frozen, donor-derived, blood plasma-based eye serum manufactured from bovine plasma using a controlled process designed for consistency and safety. Unlike conventional autologous eye serum therapy — which requires drawing blood from the patient, processing the sample in-clinic, and decanting into dropper bottles over a 40-50 minute workflow — SeroLube is delivered as a sterile, ready-to-dispense dropper that can be stored in the clinic freezer and dispensed to the patient immediately. The product is positioned for use in corneal ulcers, indolent ulcers, corneal trauma, KCS/dry eye support, post-operative ocular care, and inflammatory ocular surface conditions, and the company frames it as supporting a Fear Free veterinary care approach by eliminating patient blood draws.
The company's business model is a one-time product sale of SeroLube, distributed exclusively through veterinary pharmaceutical and supply distributors including MWI Animal Health, Midwest Veterinary Supply, Covetrus, Vetcove, PennVet, and Veterinary Health Associates (VHA). Pricing is not publicly disclosed, and orders are routed through distributor platforms and a direct order pathway on the company's website. The primary customer segment is veterinary professionals and clinics; pet and equine owners constitute a secondary end-user audience. Marketing is concentrated in digital content (website, webinars, clinical handouts, research summaries) and distributor-led promotion, with no disclosed field sales force. The company provides no public financial data — no revenue, funding history, headcount, management team, ownership structure, or regulatory certifications are disclosed in available source material, and there is no indication of patents or trademarks on file. Company website copyright is dated 2026, and the company uses "SeroLube" as a trade name.
SeroRepair firmographics
Firmographics- Name
- SeroRepair
- Legal name
- SeroRepair
- Website
- https://serorepair.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SeroRepair is a privately-held veterinary biotechnology company that develops SeroLube, a frozen donor-derived bovine plasma eye serum sold through veterinary distributors to clinics for treating animal ocular surface conditions.
- Ownership category
- akta.pro rank
SeroRepair industry classification
Industry- Product category
- Veterinary Biologics
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Medicated Feed Additives & Premixes (Veterinary Pharmaceuticals) (HLAMAEAN)
Keywords
Where SeroRepair is headquartered
LocationHeadquarters
- HQ city
- Kaysville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
SeroRepair business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- SeroLube Product Sales: Sale of frozen plasma eye serum products to veterinary clinics and pet owners through distributor partnerships.
Go-to-market motion1 record
Distribution channels6 records
Marketing channels3 records
SeroRepair product offering
Product offeringCore offering
SeroRepair manufactures and sells SeroLube, a frozen, donor-derived, blood plasma-based eye serum for veterinary use. The product is made from bovine plasma using a controlled manufacturing process and is packaged in sterile, ready-to-dispense dropper bottles that veterinary clinics can store in a freezer and dispense immediately to patients. It eliminates the traditional 40-50 minute in-clinic blood draw and serum processing workflow required for conventional autologous eye serum therapy.
Product overview
SeroRepair is a veterinary-focused biologic company that develops practical solutions to simplify eye care for clinics, patients, and pet owners. Their product portfolio consists of a single core offering: SeroLube, a frozen, donor-derived blood plasma-based eye serum. Unlike traditional eye serum therapy that requires in-clinic blood drawing and processing, SeroLube comes ready-to-dispense in sterile dropper bottles that can be stored in the clinic freezer and sent home with patients immediately. The product is made from bovine (cow) plasma using a controlled process designed for consistency and safety.
Differentiator
Problem solved
Functional benefit
Products and services
- SeroLube A frozen, donor-derived, blood plasma-based eye serum for veterinary use, manufactured from bovine plasma via a controlled process. Packaged in sterile, ready-to-dispense dropper bottles that can be stored in a clinic freezer and sent home with the patient immediately. Provides serum-based biologic support for animal eyes, including tear-like proteins, growth factors, and anti-inflammatory mediators, to support epithelial health, surface hydration, and corneal comfort in conditions such as corneal ulcers, indolent ulcers, corneal trauma, KCS/dry eye, post-operative care, and inflammatory ocular surface conditions. Intended for use under the direction of a veterinarian as part of an appropriate treatment plan.
Quantifiable outcome
- Replaces 40-50 minute eye appointment process with ready-to-use dropper dispensing
Companies that use SeroRepair
Customer profileSegments2 records
Ideal customer profiles1 record
SeroRepair technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
SeroRepair partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- MWI Animal HealthcoreMajor veterinary distributor offering SeroLube through their platform for ordering and distribution to veterinary clinics.
- Midwest Veterinary SupplycoreRegional veterinary supply distributor providing access to SeroLube for veterinary practices in their distribution network.
- CovetruscoreGlobal animal health company distributing SeroLube as part of their veterinary pharmaceutical and supply portfolio.
- VetcoveminorVeterinary marketplace platform enabling veterinary practices to order SeroLube from multiple distributors.
- PennVetminorUniversity-affiliated veterinary supplier distributing SeroLube, potentially serving academic veterinary hospitals.
- Veterinary Health Associates (VHA)minorVeterinary buying group providing member clinics access to SeroLube at negotiated pricing through group purchasing.
Recent moves1 record
Expansion highlights4 records
SeroRepair competitors and assessment
Company assessmentBroad incumbents
- Zoetis: Zoetis is the world's largest animal health company with a broad portfolio of companion animal pharmaceuticals and biologics. It is a broad incumbent because it sells competing ocular therapeutics alongside vaccines, parasiticides, and other biologics through the same major veterinary distributors SeroRepair relies on.
- Ceva Animal Health: Ceva is a global animal health company with a sizable companion animal portfolio including ophthalmology products. It is a broad incumbent because it competes for veterinary shelf space and prescribing across multiple species and therapeutic categories rather than specializing in ocular biologics.
- Dechra Pharmaceuticals: Dechra is a global specialty veterinary pharmaceuticals company with a meaningful ophthalmology portfolio and broad companion animal distribution. It is a broad incumbent because it competes for the same veterinary prescribing decisions but operates across many therapeutic categories beyond ocular biologics.
- Virbac: Virbac is a global animal health company with a dedicated companion animal and ophthalmology presence. It is a broad incumbent because it offers competing ocular therapeutics as part of a broader portfolio and reaches US veterinary clinics through the same major distribution partners as SeroRepair.
- Vetoquinol: Vetoquinol is an established global animal health pharmaceutical company selling through veterinary distribution. It is a broad incumbent because it competes in veterinary ocular therapeutics as part of a broader species and therapeutic portfolio served by the same veterinary wholesalers that carry SeroLube.
- Elanco Animal Health (Remend): Elanco is a top-tier global animal health company whose Remend corneal repair gel is a directly competing veterinary ocular surface product. It is a broad incumbent because it sells the competing eye care product alongside a much larger pharmaceutical and biologic portfolio across companion animal and livestock markets.
Direct peers
- Aventix (Optixcare): Aventix markets Optixcare and related ocular lubricants and tear-stimulating drops for companion animals. It is a direct peer because both companies provide ready-to-use ocular surface support products sold through veterinary channels as alternatives to in-clinic compounded or processed preparations.
- Sentrx Animal Care: Sentrx develops and markets cross-linked hyaluronic acid-based eye care products (bioHAnce) for veterinary use. It is a direct peer because both companies sell biologic-style ocular surface therapeutics through veterinary distribution channels to clinics treating companion animal eye conditions.
- Dômes Pharma (TVM): Dômes Pharma's TVM division is a European veterinary ophthalmology specialist with a broad line of ocular therapeutics. It is a direct peer because it competes in the same veterinary eye care prescribing space and addresses similar ocular surface conditions in companion animals.
- I-MED Animal Health: I-MED Animal Health is a specialty veterinary ophthalmology company that sells diagnostic and therapeutic eye care products to veterinarians. It is a direct peer because both companies focus exclusively on veterinary ocular therapeutics sold through veterinary professional channels.
Market position
Weaknesses5 records
Competitive moat2 records
Key risks1 record
Key highlights1 record
Customer concentration
SeroRepair social profiles
Digital presenceSeroRepair financial estimates
Financial estimateRevenue estimate
Valuation estimate
SeroRepair leadership team
Management profileNumber of profiles
SeroRepair funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SeroRepair M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SeroRepair
What does SeroRepair do?
SeroRepair manufactures and sells SeroLube, a frozen, donor-derived, blood plasma-based eye serum for veterinary use. The product is made from bovine plasma using a controlled manufacturing process and is packaged in sterile, ready-to-dispense dropper bottles that veterinary clinics can store in a freezer and dispense immediately to patients. It eliminates the traditional 40-50 minute in-clinic blood draw and serum processing workflow required for conventional autologous eye serum therapy.
Is SeroRepair a public or private company?
SeroRepair is a private company. It is classified as unknown and is currently operating.
When was SeroRepair founded?
SeroRepair was founded in -1. It employs 1 to 10 people.
Where is SeroRepair based?
SeroRepair is headquartered in Kaysville, United States, in the North America region.
How does SeroRepair make money?
One revenue line is on record: seroLube Product Sales.
Who are SeroRepair's main competitors?
Broad incumbents on record are Zoetis, Ceva Animal Health, Dechra Pharmaceuticals, Virbac, Vetoquinol and Elanco Animal Health (Remend). Direct peers are Aventix (Optixcare), Sentrx Animal Care, Dômes Pharma (TVM) and I-MED Animal Health.
Does SeroRepair have an API?
No public API is recorded for SeroRepair.
What industry is SeroRepair in?
SeroRepair's product category is Veterinary Biologics. Its primary akta.pro industry code is HLAMAEAN, Medicated Feed Additives & Premixes (Veterinary Pharmaceuticals). Its NAICS code is 325414 and its SIC code is 2836.